Show simple item record

dc.contributor.authorAlarcón-Braga, E.A.
dc.contributor.authorHernandez-Bustamante, E.A.
dc.contributor.authorSalazar-Valdivia, F.E.
dc.contributor.authorValdez-Cornejo, V.A.
dc.contributor.authorMosquera-Rojas, M.D.
dc.contributor.authorUlloque-Badaracco, J.R.
dc.contributor.authorRondon-Saldaña, J.C.
dc.contributor.authorZafra-Tanaka, J.H.
dc.date.accessioned2025-10-31T18:47:42Z
dc.date.available2025-10-31T18:47:42Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.12805/6336
dc.description.abstractIntroduction: Vaccination represents an important strategy to mitigate COVID-19 related morbidity and mortality by protecting against severe forms of the disease and reducing hospitalization and death rates. In this sense, the objective of this study is to estimate the prevalence of Vaccination Intention (VI) against COVID-19 in Latin America and Caribbean (LAC). Methods: We conducted a systematic review with a comprehensive search strategy for the following databases: PubMed, Scopus and Web of Science. A random-effect model meta-analysis was carried out using observational studies assessing the intention to vaccines against COVID-19 in LAC countries. The Clopper-Pearson method was used to estimate 95% Confidence Intervals. The quality assessment was developed using the Newcastle-Ottawa Scale adapted for cross-sectional studies. A subgroup analysis by study location and a sensitivity analysis were developed. Results: Nineteen cross-sectional studies were included. Five meta-analyzes were performed according to the target population of the included studies. The VI in the general population of LAC was 78.0% (95%CI: 74.0%–82.0%). The VI for non-pregnant women was 78.0% (95%CI: 58.0%–99.0%), for elderly population was 63.0% (95%CI: 59.0%–69.0%), for pregnant women was 69.0% (95%CI: 61.0%–76.0%) and for health-personnel was 83.0% (95% CI: 71.0%–96.0%). The sensitivity analysis for general population meta-analysis that included only low risk of bias studies showed a 77.0% VI (95%CI: 73.0%–82.0%) and for non-pregnant women, 85.0% VI (95%CI: 79.0%–90.0%). Conclusion: Despite the high prevalence of VI in general population found in our study, VI prevalence from elderly people and pregnant women are lower than other population groups and overall population.en_US
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofurn:issn:1477-8939
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectCOVID-19, Its Impact, and Vaccinationen_US
dc.subjectVaccine Acceptance and Hesitancy Dynamicsen_US
dc.titleAcceptance towards COVID-19 vaccination in Latin America and the Caribbean: A systematic review and meta-analysisen_US
dc.typehttps://purl.org/coar/resource_type/c_dcae04bc
dc.identifier.doihttps://doi.org/10.1016/j.tmaid.2022.102369
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.00
dc.type.otherReview
dc.identifier.journalTravel Medicine and Infectious Disease
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2